Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
RPTH Journal: Rivaroxaban vs Warfarin in PE with RV Dysfunction
François Laliberté/LinkedIn
Aug 6, 2025, 12:52

RPTH Journal: Rivaroxaban vs Warfarin in PE with RV Dysfunction

RPTH Journal shared a new study on LinkedIn:

”Do clinical outcomes differ between patients treated with rivaroxaban vs warfarin for PE/RVD?

Rivaroxaban was more effective than warfarin without a significant increase in safety.”

Read the full article here.

Article: Effectiveness and safety of rivaroxaban vs warfarin in patients with pulmonary embolism and right ventricular dysfunction: a retrospective cohort study

Authors: François Laliberté, Behnood Bikdeli, Veronica Ashton, Guillaume Germain, Julien Boudreau, Manasvi Sundar, Sean D. MacKnight, Brahim Bookhart, Dereck Wentworth, Shawn Murphy, Yichuan G. Hsieh, Gregory Piazza

RPTH Journal: Rivaroxaban vs Warfarin in PE with RV Dysfunction

Find the latest scientific advances featured in Hemostasis Today.

Behnood Bikdeli Brahim Bookhart Dereck Wentworth François Laliberté Gregory Piazza Guillaume Germain Health Hematology Hemostasis Today Julien Boudreau Manasvi Sundar Medicine PE Pulmonary embolism right ventricular dysfunction Rivaroxaban Rivaroxaban vs Warfarin RPTH Journal RVD Sean D. MacKnight Shawn Murphy Veronica Ashton Warfarin Yichuan G. Hsieh
NewsFeed